BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and ...

Haemochromatosis is the most common genetic disorder in Northern Ireland and is mostly found in people of Irish and Scots ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based ...

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at ...

Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality ...

On one of Drake Maye's worst nights, the Patriots defense lifted the team to victory -- and proved they're more than just a ...

Scientists are testing CRISPR gene editing as a potential HIV cure after successfully removing the virus from infected cells ...

One prioritizes convenience and personalization. The other puts privacy first. Which one should you use? We help you decide.

NEW YORK, Jan. 11, 2026 /PRNewswire/ -- Today at NRF 2026: Retail's Big Show, Google Cloud and Authentic Brands Group (Authentic), a global brand development and licensing platform, announced a ...

The world of IVF is changing faster than ever. What once seemed like a complex, unpredictable process is now being ...

A groundbreaking cattle genome has given researchers their clearest look yet at what makes Wagyu beef so special. By ...

In about 5–10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients. Research from Radboud ...